Sen. Amy Klobuchar

Maddy summaryThis bill requires lenders using the Uniform Residential Loan Application to add a specific disclaimer below the military service question: "If yes, you may qualify for a VA Home Loan. Consult your lender regarding eligibility." It directly affects military service members and veterans applying for home loans, aiming to increase awareness of VA loan eligibility. The bill mandates this change within six months of enactment and requires a GAO study within 18 months to assess whether at least 80% of lenders include the disclaimer on the form.

Maddy summaryS 412, the SHIELD Act of 2023, creates a federal criminal offense for knowingly distributing non-consensual intimate visual depictions (such as photos or videos of someone without their consent) or visual depictions of nude minors. It directly affects individuals who distribute such content without consent, including those sharing intimate images of adults or nude photos of minors, with penalties including up to 5 years in prison and asset forfeiture. Key provisions define "intimate visual depictions" (showing genitals or engaging in sexual conduct without consent), exclude law enforcement activities and legal reporting from the ban, and require forfeiture of materials used to distribute such content. The bill aims to address non-consensual image sharing and child sexual abuse material through federal criminal penalties.

Maddy summaryThe Affordable Prescriptions for Patients Act of 2023 targets "product hopping" by pharmaceutical manufacturers, which occurs when companies discontinue an original drug to make way for a follow-on product and prevent competition from cheaper generics or biosimilars. The bill prohibits two types of anti-competitive conduct: "hard switches" (discontinuing a drug or withdrawing approval) and "soft switches" (taking actions to disadvantage the original drug relative to a follow-on product). It gives the Federal Trade Commission authority to enforce these rules, including seeking remedies like disgorgement of profits from anti-competitive behavior. This legislation directly affects drug manufacturers, particularly those producing reference drugs and follow-on products, with the goal of increasing competition in the pharmaceutical market and lowering prescription costs.

Maddy summarySRES 765 is a Senate resolution honoring the late Senator James M. Inhofe of Oklahoma following his death on July 9, 2024. The resolution commemorates his 28-year Senate service (1994-2023) and 52 years in public office, highlighting his work on defense policy, aviation legislation, infrastructure projects, and support for military bases in Oklahoma. This procedural resolution expresses the Senate's condolences and formally recognizes his legacy, rather than enacting any policy changes.

Maddy summaryThis Senate resolution (SRES 766) formally designates September 17, 2024, as "National Voter Registration Day" to encourage voter participation. It urges all voting-eligible U.S. citizens to register to vote, verify their registration details with election officials, and vote in elections. The resolution does not create new laws or requirements but serves as a symbolic recognition to promote civic engagement. It directly affects voters by highlighting a specific day for registration and voting actions. The Senate passed this non-binding resolution to raise awareness, not to mandate any changes.

Maddy summaryThe Capping Prescription Costs Act of 2024 sets a yearly limit on out-of-pocket costs for prescription drugs under most health insurance plans. Starting in 2026, individual plan members would pay no more than $2,000 annually for covered drugs, while families would pay no more than $4,000. These limits would increase each year based on inflation, adjusted using the medical care component of the Consumer Price Index. The bill applies to both individual health plans and employer-sponsored group plans covered under the Affordable Care Act. It takes effect for plans beginning after December 2025.

Maddy summaryThis bill authorizes Congress to award a single Congressional Gold Medal to Jens Stoltenberg, former Secretary General of NATO, recognizing his leadership during his nine-year tenure. It directs the Treasury to strike the medal and allows for the sale of bronze duplicates to cover costs. The medal honors Stoltenberg's role in strengthening NATO's defense spending, enlargement, and unity - particularly during Russia's invasion of Ukraine - though the bill itself creates no new policy or obligations. The award is purely ceremonial and affects only Stoltenberg as the recipient.

Maddy summaryThis bill, S 4687, authorizes a single Congressional Gold Medal to be awarded collectively to wildland firefighters for their service in protecting U.S. forests, grasslands, and communities from wildfires. The medal, designed by the Secretary of the Treasury in consultation with the National Interagency Fire Center, will be presented by congressional leaders and displayed permanently at the National Interagency Fire Center for public access and research. The bill also permits the sale of bronze duplicates at cost to the public, with proceeds covering production expenses. This commemorative measure recognizes the collective sacrifice and dedication of wildland firefighters without altering their duties or benefits.

Maddy summaryThis bill, S 4691 (No Tax Breaks for Drug Ads Act), removes a tax deduction for pharmaceutical companies that spend on direct-to-consumer advertising of prescription drugs. It directly affects drug manufacturers by eliminating the ability to deduct expenses for ads targeting the general public through TV, radio, print, online, or social media platforms. The key provision prohibits tax deductions for all such advertising costs starting after the bill's enactment date, without changing advertising rules or banning ads. This is a concrete tax policy change affecting pharmaceutical industry spending, not a regulatory measure.

Maddy summaryThe Baby Food Safety Act of 2024 establishes safety limits for toxic elements like lead, cadmium, mercury, and arsenic in infant and toddler food (not including infant formula) and foods primarily made of fruit or vegetable purees or juices. Manufacturers must implement regular testing programs for these contaminants, maintain detailed records for two years, and establish environmental monitoring to verify sanitation controls. The Food and Drug Administration must set specific limits by 2025-2028 (lead and arsenic by December 2025, cadmium by April 2026, mercury by April 2028), with regular reviews every four years. The law includes enforcement mechanisms for products exceeding established limits, directly affecting food manufacturers producing products for infants and toddlers under age two.